Blood measures in patients with COVID-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/6952

Full metadata record

DC Field	Value	Language
dc.contributor.author	Kurbonova, Z.Ch.	-
dc.contributor.author	Babadzhanova, Sh.A.	-
dc.contributor.author	Serdal, Korkmaz	-
dc.contributor.author	Muminov, O.A.	-
dc.contributor.author	Khushbokova, G.U	-
dc.date.accessioned	2023-04-06T13:46:41Z	-
dc.date.available	2023-04-06T13:46:41Z	-
dc.date.issued	2023-03	-
dc.identifier.issn	2751-1731	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/6952	-
dc.description.abstract	Сoronavirus infection mainly affects the respiratory tract, but according to the latest information, COVID-19 is a systemic disease, affecting the respiratory, cardiovascular, gastrointestinal, urinary, neurological, hematopoietic and immune systems. Purpose of research is evaluation of blood and urine analysis. Research material on COVID-19 with 200 sick patients. Research methods: general blood analysis. The degree of leukocytosis, neutrophilia and lymphocytopenia depends on the extent to damage the lungs in coronavirus infection	en_US
dc.language.iso	en	en_US
dc.publisher	Spectrum Journal of Innovation, Reforms and Development	en_US
dc.relation.ispartofseries	13;	-
dc.subject	COVID-19, blood, leukocyte, neutrophil, monocyte, lymphocyte, platelets	en_US
dc.title	Blood measures in patients with COVID-19	en_US
dc.type	Article	en_US
Appears in Collections:	Books and Book Chapters

Files in This Item:

File	Description	Size	Format
2023.03 Spectrum Blood measures in patients with Covid-19.pdf		238.69 kB	Adobe PDF	View/Open

DSpace JSPUI